Evidence map›Paper›PMID 25422124›Full record

ArticleProbiotics and antimicrobial proteins2015

Antimicrobial Effect of Lactobacillus reuteri on Cariogenic Bacteria Streptococcus gordonii, Streptococcus mutans, and Periodontal Diseases Actinomyces naeslundii and Tannerella forsythia.

Magda Lorena Baca-Castañón, Myriam Angélica De la Garza-Ramos, Andrea Guadalupe Alcázar-Pizaña, Yohann Grondin, Anahí Coronado-Mendoza, Rosa Isela Sánchez-Najera, Eloy Cárdenas-Estrada, Carlos Eduardo Medina-De la Garza, Erandi Escamilla-García

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Inhibition ofFoods (Basel, Switzerland) · 2025
    Article
  7. Mechanism of Action ofAntibiotics (Basel, Switzerland) · 2023
    Article
  8. Probiotics-Mediated Bioconversion and Periodontitis.Food science of animal resources · 2021
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Magda Lorena Baca-CastañónUnidad de Odontología Integral y Especialidades, Centro de Investigación y Desarrollo en Ciencias de la Salud (CIDICS), Universidad Autónoma de Nuevo León (UANL), Ave. Carlos Canseco s/n con Ave. Gonzalitos, Mitras Centro, CP: 64460, Monterrey, Nuevo León, Mexico.
Myriam Angélica De la Garza-Ramos
Andrea Guadalupe Alcázar-Pizaña
Yohann Grondin
Anahí Coronado-Mendoza
Rosa Isela Sánchez-Najera
Eloy Cárdenas-Estrada
Carlos Eduardo Medina-De la Garza
Erandi Escamilla-García
Universidad Autónoma de Nuevo León · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactic acid bacteria (LAB) are well known for their beneficial effects on human health in the intestine and immune system; however, there are few studies on the impact they can generate in oral health. The aim of this study was to test and compare in vitro antimicrobial activity of L. reuteri on pathogenic bacteria involved in the formation of dental caries: S. mutans, S. gordonii, and periodontal disease: A. naeslundii and T. forsythia. Also, we determined the growth kinetics of each bacterium involved in this study. Before determining the antimicrobial action of L. reuteri on cariogenic bacteria and periodontal disease, the behavior and cell development time of each pathogenic bacterium were studied. Once the conditions for good cell growth of each of selected pathogens were established according to their metabolic requirements, maximum exponential growth was determined, this being the reference point for analyzing the development or inhibition by LAB using the Kirby Bauer method. Chlorhexidine 0.12% was positive control. L. reuteri was shown to have an inhibitory effect against S. mutans, followed by T. forsythia and S. gordonii, and a less significant effect against A. naeslundii. Regarding the effect shown by L. reuteri on the two major pathogens, we consider its potential use as a possible functional food in the prevention or treatment of oral diseases.

Indexed as

AntibiosisActinomycesBacteroidetesDental CariesLimosilactobacillus reuteriPeriodontal DiseasesStreptococcus gordoniiStreptococcus mutans

Identifiers

PMID25422124
OpenAlexW2035447162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.